Open Site Navigation

TIR-C selected for IVA's 100 list


TIRmed Pharma's project to developing TIR-C has been listed by Kungliga IngenjörsVetenskapsakademien (IVA) in their annual 100 list as one of the most interesting on-going projects in Sweden.


About IVA's 100: IVA 100 highlights a variety of research projects from Swedish universities on the theme of technology in the service of humanity. By building bridges between the research world and the business community, they give research with the potential to change the world a greater opportunity to be turned into actual benefits.


Read more about TIRmed Pharma's ongoing project via https://www.iva.se/projekt/research2business/ivas-100-lista-2022/a-novel-treatment-against-atopic-dermatitis/